Advertisement
Notícias Sobre o Forex
Aclaris Therapeutics Says Will Discontinue Further Development Of ATI-450 Program
Biopharmaceutical company Aclaris Therapeutics, Inc. (ACRS) announced Monday top-line results from a Phase 2b study of zunsemetinib (ATI-450), an investigational oral MK2 inhibitor, in subjects with moderate to severe rheumatoid arthritis.
RTTNews |
644 dias atrás
Bay Street Likely To See Muted Start
Canadian shares look headed for a muted start on Monday with investors looking for direction. With U.S. inflation data due later in the week, the mood is likely to remain a bit cautious.
RTTNews
|
644 dias atrás
Essential Properties Realty Trust Appoints Scott Estes To Succeed Paul Bossidy As Chairman
Essential Properties Realty Trust, Inc. (EPRT) announced Monday that Paul Bossidy has notified the Company of his intent to retire as Chairman of the Company's Board of Directors, effective as of December 31, 2023, after nearly 7 years as Chairman.
RTTNews
|
644 dias atrás
Selecta Biosciences Merges With Cartesian Therapeutics In All-stock Deal
Selecta Biosciences, Inc. (SELB) announced Monday that it has merged with biotechnology company Cartesian Therapeutics, Inc.
RTTNews
|
644 dias atrás
Continental To Cut Thousands Of Jobs; Sees EUR 400 Mln Cost Savings
German autoparts maker Continental AG Monday announced its plans to cut thousands of jobs in its automotive unit as part of its efforts to strengthen the sector's competitiveness. Continental said its Automotive sector is simplifying and streamlining business and administrative structures.
RTTNews
|
644 dias atrás
Tyson Foods Slips To Loss In Q4; Guides FY24 Sales Below Estimates
Tyson Foods, Inc. (TSN) reported Monday a net loss attributable to the company for the fourth quarter of $450 million or $1.31 per share, compared to net income of $538 million or $1.50 per share in the prior-year quarter.
RTTNews
|
644 dias atrás
Genius Sports Q3 Loss Misses Estimates; Boosts FY23 Revenue Outlook
Genius Sports Ltd. (GENI) reported Monday that net loss for the third quarter was $11.62 million or $0.06 per share, wider than $8.97 million or $0.04 per share in the prior-year quarter.
RTTNews
|
644 dias atrás
more news
Neurocrine Biosciences Reaches Settlement On INGREZZA ANDA Litigation
Biopharmaceutical company Neurocrine Biosciences, Inc. (NBIX) announced Monday that is has resolved all patent litigation related to lawsuits resulting from Abbreviated New Drug Applications (ANDAs) brought by companies seeking approval to market a generic version of INGREZZA (valbenazine) prior to the expiration of applicable Neurocrine patents.
RTTNews
|
644 dias atrás
Avient Appoints Ashish Khandpur To Succeed Robert Patterson As President And CEO
Avient Corp. (AVNT), a provider of sustainable material solutions, announced Monday that its Board of Directors has unanimously voted to elect Dr. Ashish Khandpur as President and Chief Executive Officer, effective December 1, 2023.
RTTNews
|
644 dias atrás
Bilfinger Q3 Results Climb, Backs FY23 View; Stock Up
Bilfinger SE's shares were gaining more than 2 percent in the morning trading in Germany after the Industrial services provider Monday confirmed its fiscal 2023 forecast after reporting higher profit and revenues in its third quarter. The company noted that demand is stable across all regions and industries, while there is skepticism in the market regarding the German economy.
RTTNews
|
644 dias atrás
Pound Advances As European Shares Climb Ahead Of Inflation Data
The pound climbed against its major counterparts in the European session on Monday, as investors awaited inflation data from the U.S. and the U.K. for fresh clues on the policy outlook.
RTTNews
|
644 dias atrás
U.S. Dollar Falls Against Most Majors
The U.S. dollar weakened against most major currencies in the European session on Monday.
RTTNews
|
644 dias atrás
Sensex, Nifty End Lower On Rate Worries
Indian shares ended Monday's session lower as investors awaited key U.S. inflation data for important clues on the likelihood of another U.S. interest rate hike in December.
RTTNews
|
644 dias atrás
Stay up to date!
Add Notícias to your browser
Add To Chrome
